A new technology has been developed to suppress immune rejection, the biggest challenge in organ transplantation, without causing systemic side effects. A research team from Pohang University of ...

First participant dosed in clinical trial at University of Chicago Medicine assessing the use of tegoprubart to prevent islet cell transplant rejection in patients with type 1 diabetes Company reports ...

When a donor organ is given to a recipient, it’s crucial that the recipient's immune system does not attack the donated organ as an invader... | Cell And Molecular Biology ...

A cell treatment to prevent new organs being rejected without the need for lifelong courses of immune drugs is showing promise in mice and may one day make human transplants easier, scientists said.

Add Yahoo as a preferred source to see more of our stories on Google. Eledon's kidney transplant rejection drug Eledon Pharmaceuticals’ lead asset, tegoprubart, is going to late-stage trials in kidney ...

When a transplanted organ arrives, it’s like a controlled burn that risks becoming a wildfire. The body’s innate immune system senses damage signals, like heat shock proteins (HSP70), and sounds the ...

Data from 11 participants demonstrates tegoprubart successfully prevented kidney transplant rejection and was generally safe and well-tolerated Aggregate mean eGFR was above 70 mL/min/1.73m 2 at all ...

If an organ in your body (such as the heart, kidneys, or liver) is not working well enough because of an illness or injury, you may need an organ transplant. An organ transplant involves surgically ...

Novartis Pharmaceuticals, based in East Hanover, NJ, has received FDA approval of Zortress (everolimus) oral tablets for preventing rejection of kidney transplants in adult patients at low-to-moderate ...

CARY, N.C., Jan. 21, 2026 /PRNewswire/ -- Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument (also ...

Scientists at Duke University say they’ve successfully prevented organ rejection in nonhuman primates that have undergone kidney transplants. Their secret? An antibody engineered in the lab to help ...

Researchers at UC San Francisco (UCSF) have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant ...